Tale of two Indians: Heterogeneity in type 2 diabetes pathophysiology

被引:32
|
作者
Staimez, Lisa R. [1 ]
Deepa, Mohan [2 ,3 ]
Ali, Mohammed K. [1 ]
Mohan, Viswanathan [2 ,3 ]
Hanson, Robert L. [4 ]
Narayan, K. M. Venkat [1 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Emory Global Diabet Res Ctr, Atlanta, GA USA
[2] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India
[3] Dr Mohans Diabet Special Ctr, Chennai, Tamil Nadu, India
[4] NIDDK, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ USA
关键词
epidemiology; ethnicity; insulin resistance; insulin secretion; pathophysiology; type; 2; diabetes; IMPAIRED FASTING GLUCOSE; BETA-CELL FUNCTION; PIMA-INDIANS; INSULIN-RESISTANCE; RACIAL/ETHNIC GROUPS; NORMAL-WEIGHT; PREVALENCE; RISK; INDIVIDUALS; POPULATION;
D O I
10.1002/dmrr.3192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Type 2 diabetes is a heterogeneous disease and may manifest from multiple disease pathways. We examined insulin secretion and insulin resistance across two ethnicities with particularly high risk for diabetes yet with widely different distributions of weight class. Materials and Methods In this population-based, cross-sectional study, Pima Indians from Southwestern United States (n = 865) and Asian Indians from Chennai, India (n = 2374) had a 75-g oral glucose tolerance test. We analysed differences in plasma glucose, plasma insulin, insulin resistance (HOMA-IR), and insulin secretion (Delta I0-30/Delta G(0-30)) across categories of body mass index (BMI) and glycemic status per American Diabetes Association criteria. Results Pima Indians were younger (mean 27.4 +/- SD 6.6, Asian: 33.9 +/- 6.7 years) and had higher BMI (33.6 +/- 8.1, Asian: 25.7 +/- 4.9 kg/m(2)). Among normal weight participants (mean BMI: Pima 22.4 SE 0.2; Asian 22.2 SE 0.06 kg/m(2)), fasting glucose was higher in Asian Indians (5.2 vs Pima: 4.8 mmol/L, P = .003), adjusted for age and sex. Pima Indians were three times as insulin resistant as Asian Indians (HOMA-IR: 7.7 SE 0.1, Asian: 2.5 SE 0.07), while Asian Indians had three times less insulin secretion (Pima: 2.8 SE 1.0 vs Asian: 0.9 SE 1.0 pmol/mmol), a pattern evident across age, BMI, and glycemic strata. Conclusions Metabolic differences between Pima and Asian Indians suggest heterogeneous pathways of type 2 diabetes in the early natural history of disease, with emphasis of insulin resistance in Pima Indians and emphasis of poor insulin secretion in Asian Indians.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Insights into the genetic architecture and pathophysiology of type 2 diabetes
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (06) : 674 - 675
  • [32] Type 2 Diabetes: An Expanded View of Pathophysiology and Therapy
    Unger, Jeff
    Parkin, Christopher G.
    POSTGRADUATE MEDICINE, 2010, 122 (03) : 145 - 157
  • [33] Role of gut microbiota in type 2 diabetes pathophysiology
    Gurung, Manoj
    Li, Zhipeng
    You, Hannah
    Rodrigues, Richard
    Jump, Donald B.
    Morgun, Andrey
    Shulzhenko, Natalia
    EBIOMEDICINE, 2020, 51
  • [34] Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
    Joe M. Chehade
    Margaret Gladysz
    Arshag D. Mooradian
    Drugs, 2013, 73 : 327 - 339
  • [35] Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
    Chehade, Joe M.
    Gladysz, Margaret
    Mooradian, Arshag D.
    DRUGS, 2013, 73 (04) : 327 - 339
  • [36] Incretins Role in the Pathophysiology of Type 2 Diabetes Mellitus
    Mythili, S., V
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (06): : 698 - 702
  • [37] NASH AND TYPE 2 DIABETES: FROM EPIDEMIOLOGY TO PATHOPHYSIOLOGY
    Petit, Jean Michel
    LIVER INTERNATIONAL, 2019, 39 (12) : 2439 - 2440
  • [38] Diabetes mellitus type 2. Pathophysiology and prevention
    Martin, S.
    Weiss, J.
    DIABETOLOGE, 2008, 4 (01): : 30 - +
  • [39] A Pathophysiology of Type 2 Diabetes Unrelated to Metabolic Syndrome
    Rottenkolber, Marietta
    Gar, Christina
    Then, Cornelia
    Wanger, Lorena
    Sacco, Vanessa
    Banning, Friederike
    Potzel, Anne L.
    Kern-Matschilles, Stefanie
    Nevinny-Stickel-Hinzpeter, Claudia
    Grallert, Harald
    Hesse, Nina
    Seissler, Jochen
    Lechner, Andreas
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05): : 1460 - 1471
  • [40] Gene expression in the pathophysiology of type 2 diabetes mellitus
    Patti M.-E.
    Current Diabetes Reports, 2004, 4 (3) : 176 - 181